ATE206457T1 - Rekombinanter gen kodierend für alpha interferon und expressionsvector dafür - Google Patents

Rekombinanter gen kodierend für alpha interferon und expressionsvector dafür

Info

Publication number
ATE206457T1
ATE206457T1 AT92122084T AT92122084T ATE206457T1 AT E206457 T1 ATE206457 T1 AT E206457T1 AT 92122084 T AT92122084 T AT 92122084T AT 92122084 T AT92122084 T AT 92122084T AT E206457 T1 ATE206457 T1 AT E206457T1
Authority
AT
Austria
Prior art keywords
expression vector
alpha interferon
gene coding
recombinant gene
coding alpha
Prior art date
Application number
AT92122084T
Other languages
English (en)
Inventor
Joong Myung Cho
Young Woo Park
Soon Jae Park
Tae Ok Bae
Ho Jin Chang
Original Assignee
Lucky Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019910025878A external-priority patent/KR930008976B1/ko
Priority claimed from KR1019910025879A external-priority patent/KR940001308B1/ko
Priority claimed from KR1019920001155A external-priority patent/KR950004014B1/ko
Application filed by Lucky Ltd filed Critical Lucky Ltd
Application granted granted Critical
Publication of ATE206457T1 publication Critical patent/ATE206457T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92122084T 1991-12-31 1992-12-29 Rekombinanter gen kodierend für alpha interferon und expressionsvector dafür ATE206457T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019910025878A KR930008976B1 (ko) 1991-12-31 1991-12-31 인간 알파인터페론 유전자의 발현벡터
KR1019910025879A KR940001308B1 (ko) 1991-12-31 1991-12-31 인간 알파 인터페론 유전자 및 발현벡터
KR1019920001155A KR950004014B1 (ko) 1992-01-28 1992-01-28 재조합 알파 인터페론의 개선된 정제 방법

Publications (1)

Publication Number Publication Date
ATE206457T1 true ATE206457T1 (de) 2001-10-15

Family

ID=27348802

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92122084T ATE206457T1 (de) 1991-12-31 1992-12-29 Rekombinanter gen kodierend für alpha interferon und expressionsvector dafür

Country Status (6)

Country Link
EP (2) EP0553494B1 (de)
CN (1) CN1062014C (de)
AT (1) ATE206457T1 (de)
AU (1) AU648214B2 (de)
ES (1) ES2165352T3 (de)
TW (1) TW242653B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0679718T3 (da) * 1994-04-09 2001-10-22 Hoffmann La Roche Fremgangsmåde til fremstilling af alfa-interferon
CA2285676C (en) 1997-04-04 2011-03-08 Donald P. Weeks Methods and materials for making and using transgenic dicamba-degrading organisms
US7105724B2 (en) 1997-04-04 2006-09-12 Board Of Regents Of University Of Nebraska Methods and materials for making and using transgenic dicamba-degrading organisms
DE19748734A1 (de) * 1997-11-05 1999-05-06 Biotechnolog Forschung Gmbh Verfahren zur Gewinnung von biologisch aktiven Dimeren von rekombinanten humanen Wachstumsfaktoren aus der Cystein-Knoten-Familie sowie Verwendung der gewonnenen Dimere
CN101255188A (zh) * 1998-11-12 2008-09-03 先灵公司 干扰素同种型的转化方法及其产物
CN1113964C (zh) * 1999-05-25 2003-07-09 上海华新生物高技术有限公司 人工合成的干扰素α－2b基因在大肠杆菌中的高效表达
WO2002031178A1 (en) * 2000-10-12 2002-04-18 Uab Research Foundation An artificial gene and vectors for expressing high-yield recombinant ovine interferon-tau in pichia pastoris
JP2005505494A (ja) * 2001-02-23 2005-02-24 イミュネックス・コーポレーション 活性タンパク質の回収増加
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
RU2238758C2 (ru) * 2002-07-24 2004-10-27 Закрытое акционерное общество "Вектор-Медика" Водный раствор интерферона-альфа-два человека для инъекций
JP5553963B2 (ja) 2004-10-22 2014-07-23 アムジエン・インコーポレーテツド 組換え抗体をリフォールディングする方法
CN1746306B (zh) * 2005-08-02 2010-08-25 成都地奥制药集团有限公司 一种重组人干扰素α4编码cDNA序列及其制备方法和应用
US7855326B2 (en) 2006-06-06 2010-12-21 Monsanto Technology Llc Methods for weed control using plants having dicamba-degrading enzymatic activity
AR063316A1 (es) 2006-10-16 2009-01-21 Monsanto Technology Llc Metodos y composiciones para mejorar el estado sanitario de plantas
US7838729B2 (en) 2007-02-26 2010-11-23 Monsanto Technology Llc Chloroplast transit peptides for efficient targeting of DMO and uses thereof
CN101818154B (zh) * 2010-03-26 2012-12-26 华南农业大学 编码猪α干扰素的基因片段及其应用
CN108911323B (zh) * 2018-06-27 2021-04-23 湖北远大生物技术有限公司 一种酶促反应l-胱氨酸母液的再利用工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
ZA844082B (en) * 1983-06-01 1985-09-25 Hoffmann La Roche Polypeptides having interferon activity
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
DE3511011A1 (de) * 1985-03-27 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
US4751078A (en) * 1985-07-03 1988-06-14 Nagabhushan Tattanahalli L Process for the purification of gamma interferon
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
JPH02145193A (ja) * 1988-11-19 1990-06-04 Lotte Confectionery Co Ltd 遺伝子の組換えによる酵母でのヒト・アルファ・インターフェロンの製造方法

Also Published As

Publication number Publication date
TW242653B (de) 1995-03-11
EP0553494A1 (de) 1993-08-04
AU3037192A (en) 1993-07-08
EP0553494B1 (de) 2001-10-04
EP1097995A1 (de) 2001-05-09
CN1073977A (zh) 1993-07-07
ES2165352T3 (es) 2002-03-16
AU648214B2 (en) 1994-04-14
CN1062014C (zh) 2001-02-14

Similar Documents

Publication Publication Date Title
ATE206457T1 (de) Rekombinanter gen kodierend für alpha interferon und expressionsvector dafür
MX9206041A (es) Proceso para producir interferon inmune humano.
AU7372687A (en) Recombinant purified protease nexin
MY103892A (en) Interleukin-2 of high purity production and use
CA2096418A1 (en) Expression of pace in host cells and methods of use thereof
ATE69466T1 (de) Superoxyddismutase.
BR9406998A (pt) Construção de DNA vetor de expressão recombinante célula processo para produzir uma enzima demonstrando atividade proteolítica enzima enzima com atividade protease preparação de enzima e uso de uma enzima
NZ217388A (en) Repressible yeast promoters and activation sequences
DK0934424T3 (da) Fremgangsmåde til fremstilling af et rekombinant polypeptid, hvorved der adderes en inhibitor for metal-afhængige proteaser eller chymotrypsiner til cellekulturmediet
ATE458817T1 (de) Klonierung und rekombinante herstellung von phospholipase aus vespidae und immunologische therapien darauf basierend
DK0722336T3 (da) Rekombinant kaffebönne alfa-galactosidase
MY102257A (en) Production and use of a novel t-cell suppressor factor
DE3850774D1 (de) Rinder-interleukin-1-alpha.
SE8701934D0 (sv) Enhanced expression of human interleukin-2 in mammalian cells
EP0260404A3 (en) Amylolytic enzymes producing microorganisms constructed by recombinant dna technology and their use for fermentation processes
DE3479734D1 (en) Novel, physiologically active polypeptides and production method thereof
IL90947A (en) Method for production of hiv protease in transformed cells, dna and vectors comprising said dna used in said production
NO177065C (no) Framgangsmåte for framstilling av enzymatisk aktivt humant lysozym
ES2056123T3 (es) Clonacion del gen que codifica la enzima isoamilasa y su empleo en la produccion de dicha enzima.
PT87332A (pt) Method of purification of product of expression of recombinant ferment
EP0241448A3 (de) Herstellung eines Plasminogenaktivators aus normalen menschlichen Dickdarmzellen
ES8606402A1 (es) Un procedimiento para preparar una molecula de adn recom- biante
EP0274560A3 (de) Menschlicher, das hämatopoietische Zellwachstum aktivierender Faktor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification